Southlake, Texas, Sept. 20, 2022 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), a medical technology company focused on ...
Southlake, Texas, April 24, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. (HSCS) d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the ...
BELGRADE, Serbia—An artificial intelligence algorithm for interpreting electrocardiograms (AI-ECG) can identify individuals who have subclinical heart failure (HF) when echocardiography isn’t widely ...
Repolarization dispersion has been linked to echocardiographic measures of diastolic dysfunction in past research, and a recent study found it potentially indicative of pulmonary arterial hypertension ...
In a 4.3-year follow-up study, few asymptomatic patients with preclinical left ventricular diastolic dysfunction (LVDD) progressed to heart failure with preserved ejection fraction (HFpEF), with a ...
Southlake, Texas, March 26, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (AI)-powered ...
Please provide your email address to receive an email when new articles are posted on . In this cross-sectional study utilizing electrocardiography (ECG) and 2D echocardiography, Munje and colleagues ...
Southlake, Texas, April 24, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (AI)-powered ...
Southlake, Texas, March 26, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. (HSCS) d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback